SCHEMBL7259506

SCHEMBL7259506

[CH2]COc1c(C)c(C)nc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.47
PDE10A Q9Y233 1/20 0.46
POLB P06746 1/20 0.46
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1A2 P05177 1/20 0.43
HPGD P15428 1/20 0.43
NUDT1 P36639 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
MAPK1 P28482 1/20 0.41
MAPT P10636 2/20 0.41
CASP3 P42574 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
HTT P42858 2/20 0.40
STAT3 P40763 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3968650 0.81 GPR3 (0.52) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL23999688 0.79 POLB (0.68) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL1278314 0.72 PDE10A (0.57) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL5502106 0.72 GPR3 (0.46) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL231530 0.72 GPR3 (0.64) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL293600 0.71 CYP1A2 (0.40) ALDH1A1HSD17B10CYP1A2HPGDL3MBTL1
SCHEMBL3966414 0.71 GPR3 (0.57) GPR3PDE10APOLBALDH1A1HSD17B10
SCHEMBL27999098 0.70 GPR3 (0.52) GPR3PDE10APOLBALDH1A1HSD17B10
Ammonia Solution, Strong SCHEMBL28822932 0.70 GPR3 (0.61) GPR3PDE10APOLBALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL27521191 0.70 GPR3 (0.61) GPR3PDE10APOLBALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003053941-A2 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-ALPHA CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2003-07-03 WO disclosed